Literature DB >> 2504436

High-output external fistulae of the small bowel: management with continuous enteral nutrition.

E Lévy1, P Frileux, P H Cugnenc, J Honiger, J M Ollivier, R Parc.   

Abstract

Three hundred and thirty-five patients with high-output enterocutaneous fistulae arising from the small intestine are reported. Median fistula output was 1350 ml/24 h. Eighty-two per cent of patients were referred from other institutions. The fistula opening was associated with evisceration in 165 cases (49 per cent). One or more severity factors were present in 75.5 per cent of the patients. Patients were divided into three groups according to their initial therapy: 21 patients (6 per cent) referred in a moribund state were not operated on (non-intervention); 80 patients (24 per cent) were operated on as an emergency, and the fistula was either exteriorized or defunctioned; 234 patients (70 per cent) were initially managed conservatively. Appropriate local care and nutrition were provided in all cases. Enteral nutrition was the exclusive nutritional support in 285 patients (85 per cent). In 92 cases with proximal fistulae, methods limiting the fistula output or allowing reinfusion of chyme were required. The overall mortality rate was 34 per cent: 100 per cent in the non-intervention group, 55 per cent after emergency surgery, and 19 per cent after conservative treatment. In the latter group, spontaneous closure was obtained in 88 patients (38 per cent). Overall mortality rate was reduced to 19 per cent in patients treated since 1980. Enteral nutrition with appropriate local care may be used in the majority of high-output enterocutaneous fistulae, with an acceptable rate of spontaneous closure. Conservative management is the treatment of choice in the initial period. Emergency surgery should be restricted to the treatment of haemorrhage or intra-abdominal abscesses associated with uncontrolled systemic sepsis.

Entities:  

Mesh:

Year:  1989        PMID: 2504436     DOI: 10.1002/bjs.1800760708

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  29 in total

1.  Sequential changes of body composition in patients with enterocutaneous fistula during the 10 days after admission.

Authors:  Xin-Bo Wang; Jian-An Ren; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  The failing gut: causes and consequences.

Authors:  Jacquelyn A H Harvey
Journal:  Clin Med (Lond)       Date:  2010-10       Impact factor: 2.659

Review 3.  Current management of enterocutaneous fistula.

Authors:  Amy R Evenson; Josef E Fischer
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

4.  Chyme Reinfusion Is Associated with Lower Rate of Postoperative Ileus in Crohn's Disease Patients After Stoma Closure.

Authors:  Ming Duan; Lei Cao; Lei Gao; Jianfeng Gong; Yi Li; Weiming Zhu
Journal:  Dig Dis Sci       Date:  2019-07-31       Impact factor: 3.199

Review 5.  Topical negative pressure wound therapy: a review of its role and guidelines for its use in the management of acute wounds.

Authors:  Estas Bovill; Paul E Banwell; Luc Teot; Elof Eriksson; Colin Song; Jim Mahoney; Ronny Gustafsson; Raymund Horch; Anand Deva; Ian Whitworth
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

6.  Metabolic support of the enterocutaneous fistula patient.

Authors:  Joshua I S Bleier; Traci Hedrick
Journal:  Clin Colon Rectal Surg       Date:  2010-09

Review 7.  Enterocutaneous Fistula: Proven Strategies and Updates.

Authors:  Irena Gribovskaja-Rupp; Genevieve B Melton
Journal:  Clin Colon Rectal Surg       Date:  2016-06

8.  Management of enterocutaneous fistulas.

Authors:  Manish Kaushal; Gordon L Carlson
Journal:  Clin Colon Rectal Surg       Date:  2004-05

9.  High-output fistula.

Authors:  Naila Arebi; Alastair Forbes
Journal:  Clin Colon Rectal Surg       Date:  2004-05

10.  Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience.

Authors:  Daniel Edgardo Wainstein; Ernesto Fernandez; Daniel Gonzalez; Osvaldo Chara; Dario Berkowski
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.